1 / 29

Prostate Cancer

Prostate Cancer. James B. Benton,M.D. Prostate Cancer. Significant of the clinical problem Early detection/screening Prevention/Management. Prostate Cancer. 220,000 new case per year in US 380,000 cases projected in 2025 40,000 death per year

mardi
Download Presentation

Prostate Cancer

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Prostate Cancer James B. Benton,M.D.

  2. Prostate Cancer • Significant of the clinical problem • Early detection/screening • Prevention/Management

  3. Prostate Cancer • 220,000 new case per year in US • 380,000 cases projected in 2025 • 40,000 death per year • Second largest cancer killer after lung cancer. • Probably #1 in non-smokers.

  4. Lifetime risk of diagnosis of prostate cancer is 17% • Lifetime risk of death from prostate cancer is 3.4% • Autopsy series (22 -55% incidence of prostate cancer)

  5. Epidemiology • The incidence and mortality of prostate cancer is quite varied among different populations • The incidence rate among African Americans is 224/100,000 and American Indians..46/100,000

  6. Epidemiology Cont’d • African-American men have the highest mortality in the world (54/100,000) • A high mortality rate has also been noted in African heritage in Brazil , Jamaica, and in sub-Saharan Africans.

  7. Epidemiology Cont’d • In 1990, 172,596 cases….33011 deaths • 149,631 whites….25,281 deaths • 17,417 blacks….5,181 deaths • 4,291 Hispanics….727 deaths • <400 Orientals….<70 deaths

  8. African American (AA) men historically presented with more advanced disease, and an increased death rate. • Because of early detection and more aggressive treatments, survival may be equilibrating.

  9. Age Specific PSA

  10. Age Specific PSA..cont’d

  11. Age Specific PSA..cont’d

  12. Age Specific PSA..cont’d

  13. Prevention • Restrict excessive fat and/or carbohydrates • ?Vitamins/Minerals: Selenium and Vitamin E, and Lycopene • Annual exam: DRE and PSA at age 40-50 • ? Hormonal…ie. Proscar

  14. Prostate Cancer Prevention Trial • 18,882 men: 55y/o or older: Finasteride(Proscar) or placebo; nl DRE and PSA <3.0: 7 year study (Thompson NEJM…2003) • CAP developed in 24% of placebo and 18% proscar (25% reduction) • High grade cancers in 22% of placebo and 37% of proscar • Side effects: impotence with proscar

  15. Prostate Cancer Screening • Since introduction of the PSA in the 1980’s, there is evidence that prostate cancer mortality has decreased. • In countries not using PSA testing, prostate cancer mortality continues to rise (Denmark, Mexico, and Sweden)

  16. American Cancer Society Prostate Cancer Screening Guidelines • Beginning at age 50, all men with a ten year life expectancy should be offered both PSA and DRE annually • Men in high risk groups, such as African- Americans or those with a family history should start at age 45

  17. ACS Guidelines Cont’d • Men at an appreciably higher risk due to multiple first-degree relatives who were dx at an early age could begin at age 40 • If PSA < 1.0, no more until age 45 • If PSA 1.0 – 2.4, annual testing • If PSA > 2.4, consider biopsy

  18. American Urological Association Guidelines • All men 50 or older with a ten year life expectancy • Men 40 – 50 with first degree relative with prostate cancer or of African-American heritage background • Exams: DRE and PSA

  19. PSA Density and Free PSA • PSA density(PSAD): PSA value divided by the volume of the prostate gland: >0.15 considered abnormal. • Free PSA: unbound PSA divided by bounded PSA: < 25% is considered abnormal • Used as factors to determined the need for a biopsy when PSA is 4.0 – 10.0 range

  20. Treatment Options • Surgery • Simultaneous Radiotherapy • External Beam Radiotherapy alone • Seed Implants alone • Cryotherapy • Observation • Hormonal Ablation • ? Vaccines

  21. Treatment cont’d • Combined Radiation and Tumor-specific vaccine regimen. • Chemotherapy: Doxil +/- hormonal therapy

  22. Surgery • Traditional Radical Prostatectomy • Laparoscopic Prostatectomy • Robotic Prostatectomy

  23. Radiotherapy • Simultaneous: Seeds/XRT • Sequentially: XRT/Seeds • Seeds alone • XRT alone: IMRT- Proton/Neutron/Photons

  24. Cryotherapy • Freezing the prostate • Limited experience

  25. Hormonal Therapy • Chemical • Orchiectomy

  26. Experienmental • Vaccines • High energy microwaves therapy

  27. Learning How to Count    9    99    100

More Related